PLEASANTON, Calif., Oct. 18, 2022 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced the availability of Veeva ePRO, a key advancement in patient-centric digital trials. The application makes ...
Patient (pt) experience with a smartphone application (app) and biosensor for remote symptom monitoring during systemic cancer therapy: Qualitative findings from initial testing. This is an ASCO ...
A prospective study to evaluate the prevelance of chemobrain (CB) in patients (pts) receiving adjuvant treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback